NCT04296175
Disease-free survival (DFS) in the intention-to-treat population
Recurrence-free survival (RFS), distant disease-free survival (D-DFS), overall survival (OS) and safety
The addition of carboplatin to adjuvant anthracycline/taxane-based chemotherapy significantly improves survival outcomes with manageable toxicity in patients with high-risk early-stage TNBC
CT2025-00002
Effect of Adjuvant Carboplatin Intensified Chemotherapy versus Standard Chemotherapy on Survival in Women with High-Risk Early-Stage Triple-Negative Breast Cancer (CITRINE)
Randomized, open-label, phase 3 trial
808
